Exai Bio Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Exai Bio

Access the complete profile.

Exai Bio Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	3350 W Bayshore Rd Ste 230 Palo Alto, CA 94303

Note: Revenues for privately held companies are statistical evaluations.


Exai Bio's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Exai Bio's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Exai Bio is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Exai Bio Annual Revenue and Growth Rate

Exai Bio	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Exai Bio's revenues are gauged from an analysis of company filings.

Exai Bio's Income Statement (based on Industry Averages)

Exai Bio P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Exai Bio has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
October 11, 2022	21	99%	$71 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Exai Bio is developing and marketing. Exai Bio's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
EXAI diagnostic kits comprised of medical diagnostic reagents, antibodies, nucleotides, solvents, enzymes, and assays for testing of bodily fluids for use in disease detection and testing; medical diagnostic reagents and assays for testing of body fluids; diagnostic preparations for medical use	08/11/2023

See all trademarks and details in the Full Report.

Market Share of Exai Bio's Largest Competitors

A competitive analysis shows these companies are in the same general field as Exai Bio, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Exai Bio. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SYMPHONY INNOVATION	Palo Alto, CA	100
LUMINAR TECHNOLOGIES	Palo Alto, CA	52
EXAI BIO	Palo Alto, CA	24
BRIDGEBIO SERVICES	Palo Alto, CA	22
PALO ALTO VETERANS INSTITUTE FOR RESEARCH	Palo Alto, CA	16
PALO ALTO RESEARCH CENTER	Palo Alto, CA	9

Future Competition: Exai Bio's Fastest Growing Competitors

These companies are in the same general field as Exai Bio and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)